Sign in
4

Changes in Ownership

Starling Oncology, Inc. Filed Acc 0001079973-26-001175

Director sold 298,853 shares at $6.51 ($1,946,310)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Hively Brad · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-08-21 Sale : show line 1 in the form 10b5-1 −298,853 $6.51 $1,946,310 411,976 D
Open-market sales · 298,853 sh · avg $6.51 · $1,946,310
Loading xslF345X06/ownership.xml…